Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Senicapoc for Exercise-Induced Asthma
NCT00861185Phase 2Completed
- Sponsor
- Icagen
- Start
- Mar 2009
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of senicapoc in exercise-induced bronchoconstriction (EIB), sponsored by Icagen. Started Mar 2009; status: completed.
02
Drugs
senicapoc
03
Conditions
exercise-induced bronchoconstriction (EIB)
Beyond the preview
Go deeper on NCT00861185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00861185.